Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Tianping Pharmaceutical is a comprehensive pharmaceutical manufacturer based in Huai'an, Jiangsu Province, China. Established in 1994, the company focuses on the development, production, and distribution of chemical generic drugs across several key therapeutic areas, including cardiovascular disease, endocrinology, and gastroenterology. Its product portfolio features widely used medications such as Metformin, Amlodipine, and Omeprazole, produced in GMP-certified facilities. The company operates as a high-tech enterprise, integrating research and development with large-scale manufacturing of oral solid dosage forms like tablets and capsules. Jiangsu Tianping Pharmaceutical primarily serves the Chinese domestic market, aiming to provide high-quality and cost-effective healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 江苏天平药业.